{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:24:15Z","timestamp":1789687455612,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alpha1-antitrypsin (AAT) is a serine protease inhibitor that serves as a counterbalance to the activity of elastases, e.g., neutrophil elastase in lung tissue. AAT deficiency (AATD) is a rare disorder usually arising from mutations to the <jats:italic>SERPINA1<\/jats:italic> gene that codes for AAT. The most common AATD alleles are S and Z which produce\u2009~\u200940% and ~\u200990% reductions in serum AAT, respectively. Rare genetic variants (&gt;\u2009500 identified) can also be associated with mild to severe AATD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This report describes a novel mutation of <jats:italic>SERPINA1<\/jats:italic> producing AATD, which we have designated, Q0<jats:sub>R\u0130ZE<\/jats:sub>. This mutation was identified in a 44-year-old woman admitted with massive hemoptysis and treated with bronchial artery embolization. Computed tomography revealed centriacinar and panacinar emphysema with prominent air entrapment, atelectasis, and localized bronchiectasis. Serum AAT was &lt;\u20090.27\u00a0g\/L (below detection limit). Genetic analysis showed homozygous deletion of exons I to III.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although many <jats:italic>SERPINA1<\/jats:italic> variants have been identified, variants with large deletions and identified in a homozygous individual, as seen in this case with Q0<jats:sub>RIZE,<\/jats:sub> are uncommon. AATD is an underdiagnosed and undertreated disease. Wider screening of COPD patients could result in earlier diagnosis and treatment that could preserve lung function.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-024-02900-6","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T14:02:52Z","timestamp":1708524172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report of a novel alpha1-antitrypsin null variant in T\u00fcrkiye: Q0R\u0130ZE"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5321-3964","authenticated-orcid":false,"given":"Dilek","family":"Karado\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1836-6193","authenticated-orcid":false,"given":"\u00dcnal","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Dreger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grandoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Osaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"2900_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.rmed.2016.06.005","volume":"117","author":"A Bashir","year":"2016","unstructured":"Bashir A, Shah NN, Hazari YM, Habib M, Bashir S, Hilal N, et al. Novel variants of SERPIN1A gene: interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease. Respir Med. 2016;117:139\u201349.","journal-title":"Respir Med"},{"issue":"1","key":"2900_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.arbr.2020.04.010","volume":"57","author":"JL Lopez-Campos","year":"2021","unstructured":"Lopez-Campos JL, Casas-Maldonado F, Torres-Duran M, Medina-Gonz\u00e1lvez A, Rodriguez-Fidalgo ML, Carrascosa I, et al. Results of a Diagnostic Procedure based on Multiplex Technology on dried blood spots and buccal swabs for subjects with suspected Alpha1 Antitrypsin Deficiency. Arch Bronconeumol (Engl Ed). 2021;57(1):42\u201350.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"2900_CR3","first-page":"391","volume":"5","author":"JA Dickens","year":"2011","unstructured":"Dickens JA, Lomas DA. Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther. 2011;5:391\u2013405.","journal-title":"Drug Des Devel Ther"},{"key":"2900_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/TACG.S257511","volume":"14","author":"S Seixas","year":"2021","unstructured":"Seixas S, Marques PI. Known mutations at the cause of Alpha-1 Antitrypsin Deficiency an updated overview of SERPINA1 variation spectrum. Appl Clin Genet. 2021;14:173\u201394.","journal-title":"Appl Clin Genet"},{"issue":"1","key":"2900_CR5","first-page":"7","volume":"10","author":"Wiesemann","year":"2023","unstructured":"Wiesemann GS, Oshins RA, Flagg TO, Brantly ML. Novel SERPINA1 alleles identified through a large Alpha-1 Antitrypsin Deficiency Screening Program and Review of known variants. Chronic Obstr Pulm Dis. 2023;10(1):7\u201321.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2900_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.rmed.2016.05.002","volume":"116","author":"D Silva","year":"2016","unstructured":"Silva D, Oliveira MJ, Guimaraes M, Lima R, Gomes S, Seixas S. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal. Respir Med. 2016;116:8\u201318.","journal-title":"Respir Med"},{"issue":"1","key":"2900_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15412555.2017.1414779","volume":"15","author":"L Meira","year":"2018","unstructured":"Meira L, Boaventura R, Seixas S, Sucena M. Alpha-1 Antitrypsin Deficiency Detection in a Portuguese Population. COPD. 2018;15(1):4\u20139.","journal-title":"COPD"},{"issue":"3","key":"2900_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/jmg.2004.023903","volume":"42","author":"I Ferrarotti","year":"2005","unstructured":"Ferrarotti I, Baccheschi J, Zorzetto M, Tinelli C, Corda L, Balbi B, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet. 2005;42(3):282\u20137.","journal-title":"J Med Genet"},{"issue":"3","key":"2900_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1378\/chest.93.3.580","volume":"93","author":"DA Mahler","year":"1988","unstructured":"Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580\u20136.","journal-title":"Chest"},{"issue":"7","key":"2900_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581\u20136.","journal-title":"Thorax"},{"issue":"3","key":"2900_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/occmed\/kqm162","volume":"58","author":"C Stenton","year":"2008","unstructured":"Stenton C. The MRC breathlessness scale. Occup Med (Lond). 2008;58(3):226\u20137.","journal-title":"Occup Med (Lond)"},{"key":"2900_CR12","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 Report). Global Initiative for Chronic Obstructive Lung Disease.; 2021. Available at: https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf (Accessed 26 January 2024)."},{"issue":"3","key":"2900_CR13","first-page":"403","volume":"47","author":"H Takahashi","year":"1990","unstructured":"Takahashi H, Crystal RG. Alpha 1-antitrypsin null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons. Am J Hum Genet. 1990;47(3):403\u201313.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2900_CR14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/BF00194647","volume":"86","author":"W Poller","year":"1991","unstructured":"Poller W, Faber JP, Weidinger S, Olek K. DNA polymorphisms associated with a new \u03b11-antitrypsin PI Q0 variant (PI Q0riedenburg). Hum Genet. 1991;86(5):522\u20134.","journal-title":"Hum Genet"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02900-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-02900-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02900-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T14:03:14Z","timestamp":1708524194000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-02900-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2900"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-02900-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"9 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient described herein for their anonymized information to be published in this article. Ethics committee approval was not sought for this study because Recep Tayyip Erdo\u011fan University does not require ethical approval for reporting individual cases. This study was completed in accordance with the Helsinki Declaration as revised in 2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for their anonymized information to be published in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DK and \u00dcS have no competing interests related to this work. BD is an employee of Grifols Deutschland. LO and LG are employees of Progenika, a Grifols Company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}